Janney Montgomery Scott LLC Increases Position in Danaher Corporation $DHR

Janney Montgomery Scott LLC grew its stake in shares of Danaher Corporation (NYSE:DHR) by 7.7% in the second quarter, Holdings Channel reports. The firm owned 199,045 shares of the conglomerate’s stock after acquiring an additional 14,277 shares during the period. Janney Montgomery Scott LLC’s holdings in Danaher were worth $39,319,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of DHR. NBC Securities Inc. purchased a new stake in shares of Danaher during the first quarter valued at about $176,000. Affiance Financial LLC raised its stake in shares of Danaher by 54.6% in the first quarter. Affiance Financial LLC now owns 1,136 shares of the conglomerate’s stock worth $233,000 after purchasing an additional 401 shares during the last quarter. Merit Financial Group LLC raised its stake in shares of Danaher by 44.8% in the first quarter. Merit Financial Group LLC now owns 14,555 shares of the conglomerate’s stock worth $2,984,000 after purchasing an additional 4,505 shares during the last quarter. ST Germain D J Co. Inc. raised its stake in shares of Danaher by 18.0% in the first quarter. ST Germain D J Co. Inc. now owns 4,197 shares of the conglomerate’s stock worth $860,000 after purchasing an additional 639 shares during the last quarter. Finally, Capital Asset Advisory Services LLC raised its position in Danaher by 6.7% during the 1st quarter. Capital Asset Advisory Services LLC now owns 11,709 shares of the conglomerate’s stock worth $2,402,000 after buying an additional 736 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.20% of the company’s stock.

Danaher Trading Up 6.4%

Shares of DHR opened at $198.05 on Wednesday. The firm has a market capitalization of $141.82 billion, a P/E ratio of 42.14, a P/E/G ratio of 2.65 and a beta of 0.75. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average price of $199.55 and a 200 day moving average price of $197.31.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s revenue was up 3.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Analyst Ratings Changes

DHR has been the subject of a number of recent research reports. Bank of America reduced their price target on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Barclays reiterated an “overweight” rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, Wells Fargo & Company reduced their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $245.91.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.